文献速递糖尿病肥胖与代谢综合征

血浆神经酰胺及其他鞘脂与纵向双种族队列中糖尿病前期发病的关系

Plasma Ceramides and Other Sphingolipids in Relation to Incident Prediabetes in a Longitudinal Biracial Cohort.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

在双种族队列中嵌套病例对照研究,对140名血糖正常成人基线血浆58种鞘脂进行检测,随访5年。校正多种代谢指标后,基线血浆鞘磷脂C26:0/C26:1比值(OR 2.73,95%CI 1.172-4.408,P=0.015)和神经酰胺C18:0/C18:1比值(OR 1.236,95%CI 1.042-1.466,P=0.015)与进展为糖尿病前期显著相关。

要点

  • 基线血浆鞘磷脂C26:0/C26:1比值升高与5年内进展为糖尿病前期风险增加相关(OR 2.73)。
  • 基线血浆神经酰胺C18:0/C18:1比值升高与5年内进展为糖尿病前期风险增加相关(OR 1.236)。
  • 上述关联在校正年龄、种族、性别、BMI、空腹血糖、2小时血糖、胰岛素敏感性和胰岛素分泌后仍显著。

核心结论

  • 长链神经酰胺C18:0/C18:1和超长链鞘磷脂C26:0/C26:1的饱和与单不饱和比值可能是父母有2型糖尿病史个体糖尿病前期风险的潜在生物标志物。

研究设计与样本

  • 研究为嵌套于「双种族队列中糖尿病前期病理生物学研究」的病例对照研究,该队列为5年随访研究,在学术健康中心进行。
  • 研究对象为血糖正常的成人,共140名(50%黑人,50%女性),平均年龄48.1±8.69岁,BMI 30.1±5.78 kg/m2。
  • 发生糖尿病前期的参与者按年龄、性别和种族与未进展者进行匹配。
  • 采用液相色谱-串联质谱法检测基线血浆中58种鞘脂(神经酰胺、单己糖神经酰胺、鞘磷脂和鞘氨醇),并分析其与糖尿病前期风险的关联。

主要发现

  • 基线平均空腹血浆葡萄糖为92.7±5.84 mg/dL,2小时血浆葡萄糖为121±23.3 mg/dL。
  • 在58种鞘脂中,基线血浆鞘磷脂C26:0/C26:1比值较高与5年随访期间进展为糖尿病前期显著相关(OR 2.73,95%CI 1.172-4.408,P=0.015)。
  • 基线血浆神经酰胺C18:0/C18:1比值较高与5年随访期间进展为糖尿病前期显著相关(OR 1.236,95%CI 1.042-1.466,P=0.015)。
  • 上述关联在校正年龄、种族、性别、BMI、空腹血浆葡萄糖、2小时血浆葡萄糖、胰岛素敏感性和胰岛素分泌后仍显著。

关键数值与推荐

  • 糖尿病前期定义为空腹血糖受损或糖耐量受损。
  • 主要结局为从血糖正常进展为糖尿病前期。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Sphingolipids are linked to the pathogenesis of type 2 diabetes. OBJECTIVE: To test the hypothesis that plasma sphingolipid profiles predict incident prediabetes. DESIGN: A case-control study nested in the Pathobiology of Prediabetes in a Biracial Cohort study, a 5-year follow-up study. SETTING: Academic health center. PARTICIPANTS: Normoglycemic adults enrolled in the Pathobiology of Prediabetes in a Biracial Cohort study. Assessments included oral glucose tolerance test, insulin sensitivity, and insulin secretion. Participants with incident prediabetes were matched in age, sex, and ethnicity with nonprogressors. INTERVENTIONS: We assayed 58 sphingolipid species (ceramides, monohexosyl ceramides, sphingomyelins, and sphingosine) using liquid chromatography/tandem mass spectrometry in baseline plasma levels from participants and determined association with prediabetes risk. MAIN OUTCOME MEASURE: The primary outcome was progression from normoglycemia to prediabetes, defined as impaired fasting glucose or impaired glucose tolerance. RESULTS: The mean age of participants (N = 140; 50% Black, 50% female) was 48.1 ± 8.69 years, body mass index 30.1 ± 5.78 kg/m2, fasting plasma glucose 92.7 ± 5.84 mg/dL, and 2-hour plasma glucose 121 ± 23.3 mg/dL. Of the 58 sphingolipid species assayed, higher ratios of sphingomyelin C26:0/C26:1 (OR, 2.73 [95% CI, 1.172-4.408], P = .015) and ceramide C18:0/C18:1 (OR, 1.236 [95% CI, 1.042-1.466], P = .015) in baseline plasma specimens were significantly associated with progression to prediabetes during the 5-year follow-up period, after adjustments for age, race, sex, body mass index, fasting plasma glucose, 2-hour plasma glucose, insulin sensitivity, and insulin secretion. CONCLUSION: We conclude that the saturated-to-monounsaturated ratios of long-chain ceramide C18:0/C18:1 and very-long-chain sphingomyelin C26:0/C26:1 are potential biomarkers of prediabetes risk among individuals with parental history of type 2 diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Dagogo-Jack S, Asuzu P, Wan J, et al. Plasma Ceramides and Other Sphingolipids in Relation to Incident Prediabetes in a Longitudinal Biracial Cohort. J Clin Endocrinol Metab. 2024. PMID: 38501230. doi:10.1210/clinem/dgae179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。